Cargando…
Correction: HDAC inhibitor AR-42 decreases CD44 expression and sensitizes myeloma cells to lenalidomide
| Autores principales: | , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Impact Journals LLC
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10519243/ https://www.ncbi.nlm.nih.gov/pubmed/37747363 http://dx.doi.org/10.18632/oncotarget.28515 |
| _version_ | 1785109663001346048 |
|---|---|
| author | Canella, Alessandro Nieves, Hector Cordero Sborov, Douglas W. Cascione, Luciano Radomska, Hanna S. Smith, Emily Stiff, Andrew Consiglio, Jessica Caserta, Enrico Rizzotto, Lara Zanesi, Nicola Stefano, Volinia Kaur, Balveen Mo, Xiaokui Byrd, John C. Efebera, Yvonne A. Hofmeister, Craig C. Pichiorri, Flavia |
| author_facet | Canella, Alessandro Nieves, Hector Cordero Sborov, Douglas W. Cascione, Luciano Radomska, Hanna S. Smith, Emily Stiff, Andrew Consiglio, Jessica Caserta, Enrico Rizzotto, Lara Zanesi, Nicola Stefano, Volinia Kaur, Balveen Mo, Xiaokui Byrd, John C. Efebera, Yvonne A. Hofmeister, Craig C. Pichiorri, Flavia |
| author_sort | Canella, Alessandro |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10519243 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Impact Journals LLC |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-105192432023-09-26 Correction: HDAC inhibitor AR-42 decreases CD44 expression and sensitizes myeloma cells to lenalidomide Canella, Alessandro Nieves, Hector Cordero Sborov, Douglas W. Cascione, Luciano Radomska, Hanna S. Smith, Emily Stiff, Andrew Consiglio, Jessica Caserta, Enrico Rizzotto, Lara Zanesi, Nicola Stefano, Volinia Kaur, Balveen Mo, Xiaokui Byrd, John C. Efebera, Yvonne A. Hofmeister, Craig C. Pichiorri, Flavia Oncotarget Correction Impact Journals LLC 2023-09-25 /pmc/articles/PMC10519243/ /pubmed/37747363 http://dx.doi.org/10.18632/oncotarget.28515 Text en Copyright: © 2023 Canella et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/3.0/) (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
| spellingShingle | Correction Canella, Alessandro Nieves, Hector Cordero Sborov, Douglas W. Cascione, Luciano Radomska, Hanna S. Smith, Emily Stiff, Andrew Consiglio, Jessica Caserta, Enrico Rizzotto, Lara Zanesi, Nicola Stefano, Volinia Kaur, Balveen Mo, Xiaokui Byrd, John C. Efebera, Yvonne A. Hofmeister, Craig C. Pichiorri, Flavia Correction: HDAC inhibitor AR-42 decreases CD44 expression and sensitizes myeloma cells to lenalidomide |
| title | Correction: HDAC inhibitor AR-42 decreases CD44 expression and sensitizes myeloma cells to lenalidomide |
| title_full | Correction: HDAC inhibitor AR-42 decreases CD44 expression and sensitizes myeloma cells to lenalidomide |
| title_fullStr | Correction: HDAC inhibitor AR-42 decreases CD44 expression and sensitizes myeloma cells to lenalidomide |
| title_full_unstemmed | Correction: HDAC inhibitor AR-42 decreases CD44 expression and sensitizes myeloma cells to lenalidomide |
| title_short | Correction: HDAC inhibitor AR-42 decreases CD44 expression and sensitizes myeloma cells to lenalidomide |
| title_sort | correction: hdac inhibitor ar-42 decreases cd44 expression and sensitizes myeloma cells to lenalidomide |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10519243/ https://www.ncbi.nlm.nih.gov/pubmed/37747363 http://dx.doi.org/10.18632/oncotarget.28515 |
| work_keys_str_mv | AT canellaalessandro correctionhdacinhibitorar42decreasescd44expressionandsensitizesmyelomacellstolenalidomide AT nieveshectorcordero correctionhdacinhibitorar42decreasescd44expressionandsensitizesmyelomacellstolenalidomide AT sborovdouglasw correctionhdacinhibitorar42decreasescd44expressionandsensitizesmyelomacellstolenalidomide AT cascioneluciano correctionhdacinhibitorar42decreasescd44expressionandsensitizesmyelomacellstolenalidomide AT radomskahannas correctionhdacinhibitorar42decreasescd44expressionandsensitizesmyelomacellstolenalidomide AT smithemily correctionhdacinhibitorar42decreasescd44expressionandsensitizesmyelomacellstolenalidomide AT stiffandrew correctionhdacinhibitorar42decreasescd44expressionandsensitizesmyelomacellstolenalidomide AT consigliojessica correctionhdacinhibitorar42decreasescd44expressionandsensitizesmyelomacellstolenalidomide AT casertaenrico correctionhdacinhibitorar42decreasescd44expressionandsensitizesmyelomacellstolenalidomide AT rizzottolara correctionhdacinhibitorar42decreasescd44expressionandsensitizesmyelomacellstolenalidomide AT zanesinicola correctionhdacinhibitorar42decreasescd44expressionandsensitizesmyelomacellstolenalidomide AT stefanovolinia correctionhdacinhibitorar42decreasescd44expressionandsensitizesmyelomacellstolenalidomide AT kaurbalveen correctionhdacinhibitorar42decreasescd44expressionandsensitizesmyelomacellstolenalidomide AT moxiaokui correctionhdacinhibitorar42decreasescd44expressionandsensitizesmyelomacellstolenalidomide AT byrdjohnc correctionhdacinhibitorar42decreasescd44expressionandsensitizesmyelomacellstolenalidomide AT efeberayvonnea correctionhdacinhibitorar42decreasescd44expressionandsensitizesmyelomacellstolenalidomide AT hofmeistercraigc correctionhdacinhibitorar42decreasescd44expressionandsensitizesmyelomacellstolenalidomide AT pichiorriflavia correctionhdacinhibitorar42decreasescd44expressionandsensitizesmyelomacellstolenalidomide |